Skip to main content
Journal of Tissue Engineering logoLink to Journal of Tissue Engineering
. 2019 Feb 8;10:2041731419828950. doi: 10.1177/2041731419828950

Hydrofluoric acid treatment of titanium surfaces enhances the proliferation of human gingival fibroblasts

Maria H Pham 1, Håvard J Haugen 1,, Alessandra Rinna 1, Jan Eirik Ellingsen 2, Janne E Reseland 1
PMCID: PMC6378639  PMID: 30800262

Abstract

The attachment of implants relies on bone and soft tissue biocompatibility. The aim of this article is to investigate the effect of fluoride-modified metallic titanium (Ti) surfaces (Ti-F) on proliferation and differentiation of human gingival fibroblasts. Human gingival fibroblast cells were exposed to hydrofluoric acid–modified Ti coins (Ti-F) for 1, 3, 7, 14 and 21 days, and untreated coins were used as controls. A five- to six-fold increase in the proliferation of human gingival fibroblasts on Ti-F compared to Ti surfaces was observed. Enhanced gene expression of interleukin-6 and osteoprotegerin was found at 7 days. Increased levels of sclerostin, interleukin-6 and osteoprotegerin in the media from human gingival fibroblasts cultured on Ti-F coins were found compared to controls. Our results confirm that hydrofluoric acid–modified surface may indirectly enhance the firm attachment of implant surface to junction epithelium, soft tissue epithelium, which would give protection for underlying osseous structures making osseointegration of the dental implant possible.

Keywords: Biomaterials, hydrofluoric acid, titanium, dental implants, human gingival fibroblasts

Introduction

Fluoride modification of titanium (Ti) is one surface modification that has been introduced with successful clinically results and significant improvements in the biological responses with increased bone-to-implant contact and functional attachment.15 According to Ellingsen,6 fluoride-modified titanium implants give a firmer bone anchorage than the unmodified titanium implants. Fluoride on the titanium implant surface is suggested to have a stimulatory action on osteogenic cells and thus accelerate bone regeneration,7,8 and it has as well been reported to improve peri-implant tissue response.913

The effects of both fluoride surface modification of Ti and titanium dioxide (TiO2) on the biological response have been studied on murine osteoblast cells,14,15 human palatal mesenchymal cells,9 human mesenchymal stem cells11,16,17 and human primary osteoblasts.18 Fluoride-modified titanium surfaces have been found to stimulate both proliferation and differentiation of various cells in vitro; however, only increased proliferation of primary human osteoblasts was found in our previous study.18

Soft tissue wound healing around dental implant is complex. The long-term success of an implant depends on the classical stages of wound repair,19 and the establishment of soft tissue barrier to protect the underlying osseous structures makes osseointegration possible surrounding the implant body.20 Connective tissue cells like gingival fibroblast is the soft tissue barrier that prevents bacterial penetration and thus gingival recession and bone resorption due to inflammation.21 These cells have an important role in the development, function and regeneration of the tooth-support structures22,23 and production and maintenance of connective tissue matrix.23,24 Human gingival fibroblasts (HGFs) are also important for the implant success by inhibiting the epithelial down growth.25

Much is known about the response from osteoblasts and bone to various surface modifications of titanium implants, but less is known about the soft tissue reactions. The surface modification by hydrofluoric acid (HF) has been reported to influence cell growth and adhesion of surrounding soft tissue to the implant surface.13 In this in vitro study, we investigated whether fluoride-modified titanium implant surfaces had any effect on proliferation, differentiation and secretion of factors from primary HGFs.

Materials and methods

Metallic titanium

Coins (n = 120) of grade 2 titanium (Ti), with a diameter of 14.0 mm and a height of 1.0 mm, were grit-blasted TiO2 180–220 µm as previously described.26 All the coins went through five washing steps as described elsewhere.14 Half of the coins went through an additional surface modification procedure with 0.2 vol. % HF for 120 s, giving a fluoride-modified TiO2 surface (marked Ti-F),14 whereas the rest were left untreated (marked Ti). All coins were sterilized by gamma-irradiation at 25 kGy with a Co-60 source (Institutt for Energi teknikk, Kjeller, Norway). The coins were placed in cell culture plates, y-sterilization and kept dry until culturing of the HGF started after 1 week. The coins have been fully characterized by profilometer, atomic force microscopy (AFM), X-ray photoelectron spectroscopy (XPS), contact angle and secondary ion mass spectrometry (SIMS) as described previously.14,18

Experimental design and analysis

Cell culture

Human gingival fibroblast-1 (HGF-1; American Type Culture Collection, Manassas, VA, USA) were cultured in 75 cm2 flask in Dulbecco’s Modified Eagle’s medium (DMEM, High Glucose, PAA Laboratories, Linz, Austria) containing 10% foetal bovine serum (FBS) supplemented with 100 U/mL penicillin and 100 µg/mL streptomycin (PAA Laboratories, Linz, Austria), defined as growth medium (GM), at 37°C in a humidified atmosphere with 10% CO2. The cell culture was changed three times per week until confluence. The cells were rinsed by phosphate-buffered saline (PBS; PAA Laboratories, Linz, Austria) and detached using a trypsin/EDTA (0.05%/0.02%) solution (PAA Laboratories, Linz, Austria) for 2 min. HGFs at 90% confluence were used at passage 6. The coins were placed in 24-well plates (Multidish, Nuncleon Surface, Nunc, Roskilde, Denmark), and the HGFs were seeded from a uniform solution in a dropwise manner onto each coin. The cell culture medium was changed twice a week throughout the experiment. At 1, 3, 7, 14 and 21 days, the cell culture medium was sampled and the cells were harvested. The cell culture medium was stored at −20°C until analysis. Cells were washed once with saline prior to cell lysis and messenger RNA (mRNA) isolation. The mRNA samples were stored at −80°C until analysis. Every experiment in this study was performed with three biological replicas.

Lactate dehydrogenase activity

The cytotoxicity of the fluoride surface-modified Ti coins (n = 18) was estimated based on the activity of the cytosolic enzyme lactate dehydrogenase (LDH) in the culture medium and compared to the activity from cells cultured on Ti coins (n = 18). The LDH activity from cells incubated with sodium fluoride (NaF: 1, 10 and 100 µg/mL; Fluka BioUltra, Sigma-Aldrich, St. Louis, USA) was compared to untreated cells. The LDH activity was determined in the medium collected after 1 and 3 days, according to the manufacturer’s instructions (Roche Diagnostics, Mannheim, Germany). In total, 50 µL of each sample was incubated with 50 µL of the kit reaction mixture for 30 min in the dark at room temperature. The absorbance of the samples was measured at 492 nm in a plate reader (BioTek El x 800, BioTek Instruments Inc., Winooski, VT, USA).

Effect of fluorine on cell proliferation

The proliferation rate of HGF was measured using [3H]-thymidine incorporation on fluoride-modified and unmodified sample surfaces (n = 36). In addition, subconfluent cells on plastic were also incubated for 1 and 3 days with fresh cell culture medium with sodium fluoride (NaF: 1, 10 and 100 µg/mL) (Fluka BioUltra) as control. We want to measure the effect of the free bound fluoride from HF treatment with NaF on HGF in this study. The cells were pulsed with [3H]-thymidine 12 h prior to harvest after a protocol described in a previous study.18 The cells were counted for 3 min in a liquid scintillation counter (Packard 1900 TR, Packard Instruments, Meriden, CT, USA).

mRNA isolation

Cells were lysed in lysis/binding buffer (100 mM Tris–HCl, pH 8.0, 500 mM LiCl, 10 mM EDTA, pH 8.0, 0.5 mM dithiothreitol (DTT), and 1% sodium dodecyl sulphate (SDS)) and mRNA was isolated using magnetic beads [oligo (dT)25] as described by the manufacturer (Dynal AS, Oslo, Norway). Beads containing mRNA were resuspended in 10 mM Tris–HCl, pH 8.0, and stored at −80°C until use. One microgram of mRNA was used to synthesize complementary DNA (cDNA) using the Fermentas RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Vilnius, Lithuania) for each of the samples.

Real-time polymerase chain reaction

The reverse-transcribed cDNA was subjected to real-time reverse transcription polymerase chain reaction (RT-PCR) using SsoAdvanced SYBR Green Supermix (Bio-Rad, Hercules, CA, USA) in the CFX384TM Real-Time System (Bio-Rad). cDNA samples (1 µL in a total reaction volume of 25 µL) were analysed for both the genes of interest and the reference gene (GAPDH). Gene name and primer sequences are listed in Table 1. The thermal profile was as follows: samples were denatured at 94°C for 5 min followed by 40 cycles of annealing at 60°C for 30 s, primer extension at 72°C for 30 s, and denaturing at 95°C for 30 s. Finally, one 3-min extension cycle completed the reaction sequence. Replicates (n = 4) actions were performed in duplicate in a 96-well plate. Cycle threshold (Ct) values were obtained graphically. Gene expression was normalized to GAPDH and presented as ΔCt values. Comparison of gene expression between untreated control samples and treated samples was derived from subtraction of control ΔCt values from treatment with equation (1)

Table 1.

Primer sequences used for real-time RT-PCR assays.

Gene Sense (5′–3′) Antisense (5′–3′) Accession no.
COL3A1 GTGGTGACAAAGGTGAAACAGG ATCCTCTTTCACCTCTGTTACC NG_007404.1
Fibronectin CCAGGAGACTGTGAGCACTCC CTCCAAGTACCCCCTGAGGAA NG_012196.1
MMP-1 GGGAGCAAACACATCTGACC CCGCAACACGATGTAAGTTG NG_011740.1
TGF-β1 CTACTACGCCAAGGAGGTCAC TTGCTGAGGTATCGCCAGGAA NG_013364.1
ITGA2 TCAGGCACACCAAAGAATTG CGTCTTTCAACCAGCAGGTAA NG_008330.1
ITGB3 GTGTGCCTGGTGCTCTGAT AGCAGATTCTCCTTCAGGTCA NG_008332.2
SOST CCGGAGCTGGAGAACAACAAG GCACTGGCCGGAGCACACC NG_008078.2
TNFRSF11B GTGTCTTGGTCGCCATTTTT TGGGAGCAGAAGACATTGAA NG_012202.1
IL-6 GAAAGCAGCAAAGAGGCACT TTTCACCAGGCAAGTCTCCT NG_011640.1
GAPDH AGCCACATCGCTCAGACAC GCCCAATACGACCAAATCC NG_007073.2
RANKL TCGTTGGATCACAGCACATCA TATGGGAACCAGATGGGATGTC NG_014788

COL3A1: collagen type 3 alpha 1; MMP-1: matrix metalloproteinase-1; TGF-β1: transforming growth factor beta 1; ITGA2: integrin α2; ITGB3: integrin β3; SOST: sclerostin; TNFRSF11B: OPG; IL-6: interleukin 6; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; RANKL: receptor activator of nuclear factor kappa B ligand.

Ratio=(Etarget)ΔCttarget(controlsample)(Eref)ΔCtref(controlsample)

ΔCt values to give a ΔΔCt value, and relative gene expression was calculated as 2_ΔΔ C(t) (2ΔΔCt) and normalized to GAPDH. The efficiency of each set of primers was always higher than 90%. The method to calculate the relative mRNA expression is by ΔΔCt.27

Levels of bone markers in culture medium

Prior to analysis, the samples were concentrated five times using Microsep Centrifugal tubes with 3 kDa cut-off (Pall Life Science, Ann Arbor, MI, USA). Multianalyte profiling was performed using the Luminex 200TM system (Luminex Corporation, Austin, TX, USA) and acquired fluorescence data were analysed by the 3.1 xPONENT software (Luminex).

The level of bone markers (interleukin (IL)-6, osteoprotegerin (OPG), osteocalcin (OC), leptin, osteopontin (OPN), sclerostin (SOST), tumour necrosis factor-α (TNF-α), fibroblast growth factor 23 (FGF-23)) was determined using Milliplex Map Human Bone Panel Magnetic Bead (HBNMAG-51K; Millipore, Billerica, MA, USA). RANKL was tested using a single plex kit (HRNKLMAG-51K-01; Millipore). All analyses were performed according to the manufacturers’ protocols.

Calcium analysis

Calcium content in the cell culture medium was determined by atomic absorption spectroscopy (AAS) (Analyst 400; PerkinElmer, Norwalk, CT, USA) after 1, 3, 7, 14 and 21 days of culture. Samples and standards were prepared according to Perkin-Elmer’s analytical methods for AAS. Prior to analysis, lanthanum chloride (VWR, Fontenay-sous-Bois, France) was added to the samples and standards to a final concentration of 0.5% (w/v) in order to counteract the negative effect of phosphorus on calcium sensitivity of the spectrophotometer. The absorbance was measured at 422.7 nm using an air–acetylene flame. Calcium content was calculated by WinLab32 AA Flame software (Perkin-Elmer) using a standard curve based on calcium carbonate (Sigma-Aldrich).

Calcium deposition in cells

Alizarin red staining was used to determine the presence of calcific deposition by the HGF cells. Cells on Ti and Ti-F coins were cultured in 24-well plates (n = 36, respectively) and incubated in GM and sampled after 1, 3, 7 and 14 days. The media were changed every third day and collected. The cells were washed with PBS three times and fixed in 95% ethanol for 30 min. The cells were then stained with 1% alizarin red S (pH 4.2) for 5 min and washed with distilled water, as described elsewhere.28 The alizarin red deposition was extracted with cetylpyridinium chloride (Sigma-Aldrich) at room temperature and quantitated at 562 nm in ELx800 Absorbance Reader (BioTek instruments, Winooski, VT, USA).

Statistical analysis

The statistical analyses were conducted using SigmaPlot (V 13.0 for Windows, Systat Software Inc., Chicago, USA). Normality and equal variance tests were performed prior to the testing. The effect of fluoride-modified surface (Ti-F) was compared to the respective controls (Ti) at each time points. Data were presented as the mean ± SD when datasets were normally distributed. If datasets were not normalized, the median (Q2) and the interquartile range (IQR) were presented. Pairwise comparisons between groups and controls were made using analysis of t-test and comparison procedures with Tukey test. The significance levels were notified as followed in the figures and tables with probability of p < 0.05.

Results

LDH activity

No cytotoxic effect on fibroblasts was observed when the cells were seeded on the Ti-F compared to the Ti coins. Only the lowest concentration of NaF (1 µg/mL) in solution caused a significant higher LDH activity in the cell culture medium compared to untreated cells (Figure 1).

Figure 1.

Figure 1.

Lactate dehydrogenase (LDH) activity assay. LDH activity in culture medium from HGF (a) cultured on Ti coins with (Ti-F) and without (Ti) fluoride surface modification and (b) cultured on plastic incubated with NaF (1–100 µm/mL) (b). Values represent the mean ± SD. **p < 0.01 compared to control.

Fluoride modification of titanium enhances HGF proliferation

Ti-F induced a five- to six-fold increase in the proliferation of HGF compared to control (Ti) (p < 0.05) at 1 and 3 days. In comparison, the highest dosage of NaF (100 µg/mL) dramatically reduced the HGF proliferation after 1 and 3 days, whereas 10 and 1 µg/mL of NaF halved the proliferation rate compared to untreated cells at day 3 (Figure 2).

Figure 2.

Figure 2.

Cell proliferation measured by [3H]-Thymidine corporation in HGF cultured on fluoride surface-modified (Ti-F) coins compared to Ti (a) and in cells cultured on plastic incubated with NaF (1, 10, and 100 µg/mL) (b). Data (counts per minute (CPM)) are presented as mean ± SD. **p < 0.01 compared to control.

Fluoride modification of titanium enhances gene expression (RT-PCR) of IL-6 and OPG

A significant increase in the expression of IL-6 and OPG at days 1 and 7, and 7, respectively (p < 0.05 for all) was found in cells cultured on surface modified with fluoride compared to controls. We found no significant alteration in the expression of genes related to differentiation of fibroblasts (RANKL, COL3A1, FN1, MMP-1, TGF- β1, SOST, Integrin α2 and β3) in HGF cultures on fluoride-modified Ti coins compared to controls (Figure 3).

Figure 3.

Figure 3.

Effect of Ti and Ti-F surfaces on the gene expression of (a) IL-6 and (b) OPG in HGF. *Significant difference between Ti-F and Ti in ΔCT/CT. *p < 0.05.

Fluoride enhances the secretion of SOST, IL-6 and OPG from HGF

The secretion of IL-6, OPG and SOST was higher in cells cultured on Ti-F compared to controls at all time points tested (Figure 4). No differences were, however, found in the protein secretion of OC, leptin, OPN, TNF- α and FGF-23 to the cell culture medium from HGF cultured on Ti-F compared to those cultured on unmodified Ti coins (data not shown).

Figure 4.

Figure 4.

Secretion of (a) sclerostin (SOST), (b) IL-6, and (c) OPG to the cell culture media from HGF cultured on Ti-F surfaces compared to controls (Ti). *p < 0.05, **p < 0.01, ***p < 0.001.

No effect of fluoride modification on Ca2+ in cell culture medium of HGF

We did not find any statistically significant difference in the Ca2+ content in cell culture medium from cells cultured on coins with fluoride-modified surfaces compared to controls (Figure 5).

Figure 5.

Figure 5.

Total Ca2+ in cell culture media from human gingival fibroblast cultured on HF-modified Ti surfaces (Ti-F) compared to control (Ti). Values represent the mean ± SD.

Calcium deposition in cells

We found no significant differences in the Ca2+ deposition, measured with Alizarin red, on fluoride-modified surfaces compared to controls cultured on HGF (Figure 6).

Figure 6.

Figure 6.

Ca2+ deposition in cells on HF-modified Ti surfaces (Ti-F) compared to control (Ti). Values represent the mean ± SD.

Discussion

Surface-modified implants with HF are found to promote the early phase in osseointegration after the insertion of implants.1,29 Attachment of connective tissue to surface is one of many important determinants of implant success.30 Frojd et al.31 found that fibroblasts are directly involved with the inflammatory response, tissue remodelling, bone formation and resorption around dental implants.

In this study, we found a five- to six-fold increase in the proliferation of HGF cultured on surfaces modified with HF acid compared to controls. These results are homonymous with our previous study that showed increased cell proliferation on human primary osteoblasts cultured on the same surfaces.18 Lamolle et al.14 found a similar increase in growth, biocompatibility and no effect on differentiation of murine osteoblasts on machined titanium surface modified with HF.

Low levels of NaF in the cell culture medium induced a reduction of HGF cell proliferation. Our range of NaF concentrations was 1–100 µg/mL. Li et al.32 used concentrations ranging from 1 to 5000 µM, equivalent to a range of 0.042–209.94 g/mL, and found significant increased cell proliferation of gingival periodontal ligament (PDL) by concentrations lower than 500 µM, whereas concentrations higher than 500 µM induced reduced cell proliferation and mineralization compared to controls. Li et al. explained this reduction in cell proliferation by reduced cell viability, measured by CCK-8 activity. We observed no effect of concentrations up to 100 µg/mL on the LDH activity in the cell culture medium. The samples in this in vitro study were titanium surfaces modified with 0.2% vol HF by immersion for 120 s. Immersion in HF more than 150 s could give cell death on murine osteoblast cells.14 This surface modification with less than 1.2% fluoride concentration, described in previous study,18,33 confirmed no cytotoxic effect with no changes in the LDH activity.

In our study, we found significant increased cell proliferation, as well as the secretion and expression of IL-6, OPG and SOST in HGF on HF-modified Ti surfaces compared to untreated Ti surfaces. IL-6, an interleukin produced by several cells including gingival fibroblasts,34 is assumed to regulate immune responses in inflamed tissues. As IL-6 presumably stimulates osteoclast formation, this factor might be of importance in the study of implant biocompatibility;35 however, it has also been suggested that IL-6 may act directly on osteoclast formation and proliferation by suppressing osteoclast progenitor differentiation.36

SOST has previously been found to be expressed in gingival fibroblasts and periodontal ligament cells and may play a role in periodontal regeneration.37 In our study, we found a two to three times upregulated level of SOST in HGF cultured on HF-modified surfaces compared to untreated surfaces. According to Sutherland et al., SOST is bound to bone morphogenetic proteins (BMPs) and expressed in osteogenic cells for the anabolic bone formation. This product might modulate the activity of osteoblastic cells,38 reduce the differ-entiation of osteoprogenitor cells39 and enhance the osteoclastogenesis.

The combined enhanced levels in IL-6, OPG and SOST might promote the necessary osteoclast activation that is needed for the early inflammatory phase in bone healing and remodelling.35 Cecchinato et al.40 found a positive effect in peri-implant soft tissue response in dental implant with HF-modified surfaces and suggested that this might give a better aesthetic outcome for the implant. A soft tissue barrier with gingival attached to the abutment of the implant may improve the protection function41 during the repair and regeneration processes of wound healing.42,43 Success rate depends on stable connections between implant surface and the surrounding tissue.44 Our study showed that Ti-F induced an increase in both OPG mRNA expression and protein secretion from HGF compared to control; OPG has an inhibitory effect on osteoclast activation and bone resorption45 and may therefore have an impact on bone density.4547 The biological influence of changes in OPG expression and secretion from HGF on bone remodelling and osseointegration is dependent on the levels of RANKL. We were unable to reliably detect and quantify the levels of RANKL expression and secretion from HGF cultured on Ti and Ti-F coins.

Conclusion

HF surface modification enhanced the proliferation of HGF, whereas aqueous fluoride had the opposite effect. Our results confirm that HF-modified surface may indirectly enhance the firm attachment of implant surface to junction epithelium, soft tissue epithelium, which would give protection for underlying osseous structures making osseointegration of the dental implant possible.

Acknowledgments

The authors would like to acknowledge Aina-Mari Lian, from Faculty of Dentistry, University of Oslo, for valued contribution.

Footnotes

Declaration of conflicting interests: M.H.P., H.J.H., A.R., and J.E.E report no conflict of interest. J.E.R is a member of the COST Action CA16119 CellFit.

Funding: The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This study was supported by Research Council of Norway (FRINATEK grant number 231530).

References

  • 1. Berglundh T, Abrahamsson I, Albouy JP, et al. Bone healing at implants with a fluoride-modified surface: an experimental study in dogs. Clin Oral Implants Res 2007; 18(2): 147–152. [DOI] [PubMed] [Google Scholar]
  • 2. Mertens C, Steveling HG. Early and immediate loading of titanium implants with fluoride-modified surfaces: results of 5-year prospective study. Clin Oral Implants Res 2011; 22(12): 1354–1360. [DOI] [PubMed] [Google Scholar]
  • 3. Schliephake H, Rodiger M, Phillips K, et al. Early loading of surface modified implants in the posterior mandible – 5 year results of an open prospective non-controlled study. J Clin Periodontol 2012; 39(2): 188–195. [DOI] [PubMed] [Google Scholar]
  • 4. Hansson S, Halldin A. Alveolar ridge resorption after tooth extraction: a consequence of a fundamental principle of bone physiology. J Dent Biomech 2012; 3: PMC3425398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Cooper LF, Reside G, Stanford C, et al. A multicenter randomized comparative trial of implants with different abutment interfaces to replace anterior maxillary single teeth. Int J Oral Maxillofac Implants 2015; 30(3): 622–632. [DOI] [PubMed] [Google Scholar]
  • 6. Ellingsen JE. Pre-treatment of titanium implants with fluoride improves their retention in bone. J Mater Sci Mater Med 1995; 6: 749–753. [Google Scholar]
  • 7. Isa ZM, Schneider GB, Zaharias R, et al. Effects of fluoride-modified titanium surfaces on osteoblast proliferation and gene expression. Int J Oral Maxillofac Implants 2006; 21(2): 203–211. [PubMed] [Google Scholar]
  • 8. Monjo M, Lamolle SF, Lyngstadaas SP, et al. In vivo expression of osteogenic markers and bone mineral density at the surface of fluoride-modified titanium implants. Biomaterials 2008; 29(28): 3771–3780. [DOI] [PubMed] [Google Scholar]
  • 9. Masaki C, Schneider GB, Zaharias R, et al. Effects of implant surface microtopography on osteoblast gene expression. Clin Oral Implants Res 2005; 16(6): 650–656. [DOI] [PubMed] [Google Scholar]
  • 10. Ellingsen JE, Johansson CB, Wennerberg A, et al. Improved retention and bone-tolmplant contact with fluoride-modified titanium implants. Int J Oral Maxillofac Implants 2004; 19(5): 659–666. [PubMed] [Google Scholar]
  • 11. Cooper LF, Zhou Y, Takebe J, et al. Fluoride modification effects on osteoblast behavior and bone formation at TiO2 grit-blasted c.p. titanium endosseous implants. Biomaterials 2006; 27(6): 926–936. [DOI] [PubMed] [Google Scholar]
  • 12. Noelken R, Oberhansl F, Kunkel M, et al. Maintenance of marginal hard and soft tissue support at immediately inserted and provisionalized osseospeed profile implants – 3-year results. Clin Oral Implants Res 2014; 25: 683.23432642 [Google Scholar]
  • 13. Schiegnitz E. Evaluation of the survival and soft tissue maintenance of an implant with a sloped configuration in the posterior mandible-2 years results of a prospective multi-center study. Clin Oral Implant Res 2015; 26: 367. [DOI] [PubMed] [Google Scholar]
  • 14. Lamolle SF, Monjo M, Rubert M, et al. The effect of hydrofluoric acid treatment of titanium surface on nanostructural and chemical changes and the growth of MC3T3-E1 cells. Biomaterials 2009; 30(5): 736–742. [DOI] [PubMed] [Google Scholar]
  • 15. Tiainen H, Monjo M, Knychala J, et al. The effect of fluoride surface modification of ceramic TiO2 on the surface properties and biological response of osteoblastic cells in vitro. Biomed Mater 2011; 6(4): 045006. [DOI] [PubMed] [Google Scholar]
  • 16. Valencia S, Gretzer C, Cooper LF. Surface nanofeature effects on titanium-adherent human mesenchymal stem cells. Int J Oral Maxillofac Implants 2009; 24(1): 38–46. [PubMed] [Google Scholar]
  • 17. Guida L, Annunziata M, Rocci A, et al. Biological response of human bone marrow mesenchymal stem cells to fluoride-modified titanium surfaces. Clin Oral Implants Res 2010; 21(11): 1234–1241. [DOI] [PubMed] [Google Scholar]
  • 18. Pham MH, Landin MA, Tiainen H, et al. The effect of hydrofluoric acid treatment of titanium and titanium dioxide surface on primary human osteoblasts. Clin Oral Implants Res 2014; 25(3): 385–394. [DOI] [PubMed] [Google Scholar]
  • 19. Sculean A, Gruber R, Bosshardt DD. Soft tissue wound healing around teeth and dental implants. J Clin Periodontol 2014; 41(Suppl.15): S6–S22. [DOI] [PubMed] [Google Scholar]
  • 20. Geurs NC, Vassilopoulos PJ, Reddy MS. Soft tissue considerations in implant site development. Oral Maxillofac Surg Clin North Am 2010; 22(3): 387–405. [DOI] [PubMed] [Google Scholar]
  • 21. Rompen E, Domken O, Degidi M, et al. The effect of material characteristics, of surface topography and of implant components and connections on soft tissue integration: a literature review. Clin Oral Implants Res 2006; 17(Suppl. 2): 55–67. [DOI] [PubMed] [Google Scholar]
  • 22. Lekic P, Sodek J, McCulloch CA. Osteopontin and bone sialoprotein expression in regenerating rat periodontal ligament and alveolar bone. Anat Rec 1996; 244(1): 50–58. [DOI] [PubMed] [Google Scholar]
  • 23. Palaiologou AA, Yukna RA, Moses R, et al. Gingival, dermal, and periodontal ligament fibroblasts express different extracellular matrix receptors. J Periodontol 2001; 72(6): 798–807. [DOI] [PubMed] [Google Scholar]
  • 24. Biagini G, Checchi L, Pelliccioni GA, et al. In vitro growth of periodontal fibroblasts on treated cementum. Quintessence Int 1992; 23(5): 335–340. [PubMed] [Google Scholar]
  • 25. Chehroudi B, Gould T, Brunette DM. The role of connective tissue in inhibiting epithelial downgrowth on titanium-coated percutaneous implants. J Biomed Mater Res 1992; 26(4): 493–515. [DOI] [PubMed] [Google Scholar]
  • 26. Ronold HJ, Ellingsen JE. Effect of micro–roughness produced by TiO2 blasting – tensile testing of bone attachment by using coin-shaped implants. Biomaterials 2002; 23(21): 4211–4219. [DOI] [PubMed] [Google Scholar]
  • 27. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29(9): e45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Dahl LK. A simple and sensitive histochemical method for calcium. Proc Soc Exp Biol Med 1952; 80(3): 474–479. [DOI] [PubMed] [Google Scholar]
  • 29. Stanford CM, Barwacz C, Raes S, et al. Multicenter clinical randomized controlled trial evaluation of an implant system designed for enhanced primary stability. Int J Oral Maxillofac Implants 2016; 31(4): 906–915. [DOI] [PubMed] [Google Scholar]
  • 30. Kim H, Murakami H, Chehroudi B, et al. Effects of surface topography on the connective tissue attachment to subcutaneous implants. Int J Oral Maxillofac Implants 2006; 21(3): 354–365. [PubMed] [Google Scholar]
  • 31. Frojd V, Wennerberg A, FrankeStenport V. Importance of Ca(2+) modifications for osseointegration of smooth and moderately rough anodized titanium implants – a removal torque and histological evaluation in rabbit. Clin Implant Dent Relat Res 2012; 14(5): 737–745. [DOI] [PubMed] [Google Scholar]
  • 32. Li KQ, Jia SS, Ma M, et al. Effects of fluoride on proliferation and mineralization in periodontal ligament cells in vitro. Braz J Med Biol Res 2016; 49(8): pii:S0100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Lamolle SF, Monjo M, Lyngstadaas SP, et al. Titanium implant surface modification by cathodic reduction in hydrofluoric acid: surface characterization and in vivo performance. J Biomed Mater Res A 2009; 88(3): 581–588. [DOI] [PubMed] [Google Scholar]
  • 34. Okada N, Kobayashi M, Mugikura K, et al. Interleukin-6 production in human fibroblasts derived from periodontal tissues is differentially regulated by cytokines and a glucocorticoid. J Periodontal Res 1997; 32(7): 559–569. [DOI] [PubMed] [Google Scholar]
  • 35. Redlich K, Smolen JS. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov 2012; 11(3): 234. [DOI] [PubMed] [Google Scholar]
  • 36. Yoshitake F, Itoh S, Narita H, et al. Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways. J Biol Chem 2008; 283(17): 11535–11540. [DOI] [PubMed] [Google Scholar]
  • 37. Gruber M, Gruber R, Agis H. Transforming growth factor-β1 increases sclerostin in fibroblasts of the periodontal ligament and the gingiva. Matters Archive 2017; 5: 22. [Google Scholar]
  • 38. Winkler DG, Sutherland MK, Geoghegan JC, et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 2003; 22(23): 6267–6276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Sutherland MK, Geoghegan JC, Yu C, et al. Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation. Bone 2004; 35(4): 828–835. [DOI] [PubMed] [Google Scholar]
  • 40. Cecchinato D, Lops D, Salvi GE, et al. A prospective, randomized, controlled study using OsseoSpeed™ implants placed in maxillary fresh extraction socket: soft tissues response. Clin Oral Implants Res 2015; 26(1): 20–27. [DOI] [PubMed] [Google Scholar]
  • 41. Gomez-Florit M, Ramis JM, Xing R, et al. Differential response of human gingival fibroblasts to titanium- and titanium-zirconium-modified surfaces. J Periodontal Res 2014; 49(4): 425–436. [DOI] [PubMed] [Google Scholar]
  • 42. Bartold P, Walsh LJ, Narayanan AS. Molecular and cell biology of the gingiva. Periodontol 2000; 24: 28–55. [DOI] [PubMed] [Google Scholar]
  • 43. Abiko Y, Hiratsuka K, Kiyama-Kishikawa M, et al. Profiling of differentially expressed genes in human gingival epithelial cells and fibroblasts by DNA microarray. J Oral Sci 2004; 46(1): 19–24. [DOI] [PubMed] [Google Scholar]
  • 44. Eisenbarth E, Meyle J, Nachtigall W, et al. Influence of the surface structure of titanium materials on the adhesion of fibroblasts. Biomaterials 1996; 17(14): 1399–1403. [DOI] [PubMed] [Google Scholar]
  • 45. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89(2): 309–319. [DOI] [PubMed] [Google Scholar]
  • 46. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93(2): 165–176. [DOI] [PubMed] [Google Scholar]
  • 47. Akatsu T, Murakami T, Nishikawa M, et al. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. Biochem Biophys Res Commun 1998; 250(2): 229–234. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Tissue Engineering are provided here courtesy of SAGE Publications

RESOURCES